HomeCompareCMPVF vs ARCC

CMPVF vs ARCC: Dividend Comparison 2026

CMPVF yields 0.17% · ARCC yields 10.65%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CMPVF wins by $11.9K in total portfolio value· pulled ahead in Year 8
10 years
CMPVF
CMPVF
● Live price
0.17%
Share price
$33.66
Annual div
$0.06
5Y div CAGR
76.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$36.4K
Annual income
$7,577.64
Full CMPVF calculator →
ARCC
Ares Capital Corporation
● Live price
10.65%
Share price
$18.02
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.14
Full ARCC calculator →

Portfolio growth — CMPVF vs ARCC

📍 CMPVF pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMPVFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CMPVF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CMPVF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMPVF
Annual income on $10K today (after 15% tax)
$14.83/yr
After 10yr DRIP, annual income (after tax)
$6,440.99/yr
ARCC
Annual income on $10K today (after 15% tax)
$905.66/yr
After 10yr DRIP, annual income (after tax)
$0.97/yr
At 15% tax rate, CMPVF beats the other by $6,440.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMPVF + ARCC for your $10,000?

CMPVF: 50%ARCC: 50%
100% ARCC50/50100% CMPVF
Portfolio after 10yr
$30.4K
Annual income
$3,789.39/yr
Blended yield
12.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

CMPVF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
1.6
Piotroski
6/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+21.4% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMPVF buys
0
ARCC buys
0
No recent congressional trades found for CMPVF or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMPVFARCC
Forward yield0.17%10.65%
Annual dividend / share$0.06$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR76.7%-50%
Portfolio after 10y$36.4K$24.5K
Annual income after 10y$7,577.64$1.14
Total dividends collected$15.4K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: CMPVF vs ARCC ($10,000, DRIP)

YearCMPVF PortfolioCMPVF Income/yrARCC PortfolioARCC Income/yrGap
1$10,731$30.83$11,373$532.74$642.00ARCC
2$11,537$54.63$12,608$279.46$1.1KARCC
3$12,441$96.98$13,809$142.90$1.4KARCC
4$13,485$172.71$15,042$72.20$1.6KARCC
5$14,738$309.14$16,341$36.27$1.6KARCC
6$16,327$557.96$17,732$18.18$1.4KARCC
7$18,491$1,020.80$19,231$9.10$740.00ARCC
8← crossover$21,695$1,909.16$20,851$4.55+$844.00CMPVF
9$26,912$3,698.99$22,605$2.28+$4.3KCMPVF
10$36,374$7,577.64$24,504$1.14+$11.9KCMPVF

CMPVF vs ARCC: Complete Analysis 2026

CMPVFStock

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.

Full CMPVF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this CMPVF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMPVF vs SCHDCMPVF vs JEPICMPVF vs OCMPVF vs KOCMPVF vs MAINCMPVF vs HTGCCMPVF vs GBDCCMPVF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.